60 Degrees Pharmaceuticals Announces 2024 Annual Results
Provided By GlobeNewswire
Last update: Mar 28, 2025
WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024.
Read more at globenewswire.com1.44
-0.07 (-4.64%)
NASDAQ:SXTPW (7/18/2025, 8:14:30 PM)
0.0552
0 (-8%)
Find more stocks in the Stock Screener
SXTP Latest News and Analysis
